Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06650930 · ClinicalTrials.gov registry record · Early Phase 1
Pharmacokinetics of Oral Calcium Carbonate in Parturients
A Early Phase 1 study, sponsored by Stanford University.
- Not yet
- Registry status
- Early Phase 1
- Development phase
- 60
- Enrollment target
NCT06650930: Clinical Trial Early Phase 1 study, sponsored by Stanford University.
NCT06650930 is a Early Phase 1 study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06650930, a Early Phase 1 study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study investigates the time course of change in calcium in the blood after a pregnant subject takes an oral dose of calcium carbonate (commonly marketed as "Tums"). This information is important for trials investigating whether calcium can reduce postpartum hemorrhage, bleeding after delivery.
Interventions
- DRUG Oral calcium carbonate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-01 |
| Est. Completion | 2025-10 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06650930
The ClinicalTrials.gov registry entry for NCT06650930 describes a study currently listed as not yet recruiting, categorized as Early Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral calcium carbonate is the first listed.
NCT06650930 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06650930 about?
NCT06650930 is a clinical study titled "Pharmacokinetics of Oral Calcium Carbonate in Parturients". This study investigates the time course of change in calcium in the blood after a pregnant subject takes an oral dose of calcium carbonate (commonly marketed as "Tums"). This information is important for trials investigating whether calcium can reduce postpartum hemorrhage, bleeding after delivery.
What is the current status of trial NCT06650930?
This trial is currently not yet recruiting. It is a Early Phase 1 study. The enrollment target is 60 participants. The study started on 2025-01. Estimated completion is 2025-10.
What interventions are being tested in trial NCT06650930?
The interventions under investigation include: Oral calcium carbonate (DRUG).
Who is sponsoring clinical trial NCT06650930?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.